Pages that link to "Q37278022"
Jump to navigation
Jump to search
The following pages link to B cells as therapeutic targets in autoimmune neurological disorders (Q37278022):
Displaying 50 items.
- Prevention of Hepatitis B reactivation in the setting of immunosuppression (Q26747023) (← links)
- Future perspectives in target-specific immunotherapies of myasthenia gravis (Q26776225) (← links)
- Immunomodulatory activity of interferon-beta (Q27686768) (← links)
- Mechanisms underlying inflammation in neurodegeneration (Q29617977) (← links)
- α(M)β(2)-integrin-intercellular adhesion molecule-1 interactions drive the flow-dependent trafficking of Guillain-Barré syndrome patient derived mononuclear leukocytes at the blood-nerve barrier in vitro (Q30524065) (← links)
- Novel immune response to gluten in individuals with schizophrenia (Q33798660) (← links)
- Paraneoplastic limbic encephalitis presenting as a neurological emergency: a case report (Q33813412) (← links)
- Anti-neural antibody reactivity in patients with a history of Lyme borreliosis and persistent symptoms (Q33965485) (← links)
- Changes in B- and T-lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis. (Q34052870) (← links)
- Practical considerations on the use of rituximab in autoimmune neurological disorders (Q34409447) (← links)
- Immunotherapy of inflammatory myopathies: practical approach and future prospects (Q34627294) (← links)
- Autophagy, inflammation and neurodegenerative disease (Q34686890) (← links)
- Hepatitis B reactivation in the setting of chemotherapy and immunosuppression - prevention is better than cure (Q35567748) (← links)
- Pharmacological Approaches to the Management of Secondary Progressive Multiple Sclerosis (Q36353053) (← links)
- Anti-B-Cell Therapies in Autoimmune Neurological Diseases: Rationale and Efficacy Trials (Q36484465) (← links)
- Antibody deficiency associated with an inherited autosomal dominant mutation in TWEAK. (Q36729652) (← links)
- Safety and tolerability of an anti-CD19 monoclonal antibody, MEDI-551, in subjects with systemic sclerosis: a phase I, randomized, placebo-controlled, escalating single-dose study (Q36975931) (← links)
- The role of B lymphocyte stimulator (BLyS) in systemic lupus erythematosus (Q37170754) (← links)
- Elevated ATG5 expression in autoimmune demyelination and multiple sclerosis (Q37426337) (← links)
- Translational Mini-Review Series on B Cell-Directed Therapies: B cell-directed therapy for autoimmune diseases (Q37552017) (← links)
- BAFF: a local and systemic target in autoimmune diseases (Q37593590) (← links)
- Immunotherapy of myositis: issues, concerns and future prospects (Q37686069) (← links)
- Pathogenesis and Treatment of Anti-MAG Neuropathy (Q37788996) (← links)
- Monoclonal antibody therapy in multiple sclerosis: Paradigm shifts and emerging challenges (Q37814815) (← links)
- A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis (Q37818921) (← links)
- Anti-aquaporin-4 antibodies in Devic's neuromyelitis optica: therapeutic implications (Q37823233) (← links)
- Advances in the diagnosis, pathogenesis and treatment of CIDP. (Q37918316) (← links)
- Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies (Q38006761) (← links)
- Biologics and other novel approaches as new therapeutic options in myasthenia gravis: a view to the future (Q38068530) (← links)
- Pathomechanisms of inflammatory myopathies: recent advances and implications for diagnosis and therapies (Q38089081) (← links)
- B cell-directed therapies in multiple sclerosis (Q38702111) (← links)
- High incidence of peripheral blood plasmacytosis in patients with dengue virus infection (Q39519151) (← links)
- Maximizing productivity of CHO cell‐based fed‐batch culture using chemically defined media conditions and typical manufacturing equipment (Q39644298) (← links)
- Effect of vitamin D(3) supplementation on peripheral B cell differentiation and isotype switching in patients with multiple sclerosis (Q39737347) (← links)
- Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients (Q41096503) (← links)
- B-Cell Depletion with CD20 Antibodies as New Approach in the Treatment of Inflammatory and Immunological Events Associated with Spinal Cord Injury. (Q41585012) (← links)
- Pathogenic antibodies are active participants in spinal cord injury (Q42566452) (← links)
- A case of Rasmussen encephalitis treated with rituximab (Q43298052) (← links)
- B Cell Therapy for Multiple Sclerosis: Entering an Era. (Q46583404) (← links)
- Systematic review of the role of rituximab in treatment of antineutrophil cytoplasmic autoantibody-associated vasculitis, hepatitis C virus-related cryoglobulinemic vasculitis, Henoch-Schönlein purpura, ankylosing spondylitis, and Raynaud's phenomen (Q47163408) (← links)
- Long-term safety of rituximab induced peripheral B-cell depletion in autoimmune neurological diseases (Q47198384) (← links)
- Stiff person syndrome: advances in pathogenesis and therapeutic interventions (Q48751128) (← links)
- Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica (Q49978385) (← links)
- Advances in the diagnosis, immunopathogenesis and therapies of IgM-anti-MAG antibody-mediated neuropathies (Q50197158) (← links)
- Obinutuzumab, a potent anti-B-cell agent, for rituximab-unresponsive IgM anti-MAG neuropathy. (Q55117883) (← links)
- Therapeutic spectrum of interferon-β in ischemic stroke (Q57464040) (← links)
- Longitudinally persistent cerebrospinal fluid B cells can resist treatment in multiple sclerosis (Q64066412) (← links)
- Emerging oral immunomodulating agents - focus on teriflunomide for the treatment of multiple sclerosis. (Q64896077) (← links)
- Multiple Sclerosis: New Aspects of Immunopathogenesis. (Q64912153) (← links)
- Multi-Omics Reveals Impact of Cysteine Feed Concentration and Resulting Redox Imbalance on Cellular Energy Metabolism and Specific Productivity in CHO Cell Bioprocessing (Q90321698) (← links)